2,6-dimethylphenylphthalimide has been researched along with Seizures in 2 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lambert, D; Masereel, B; Poupaert, JH; Stables, JP; Vamecq, J | 1 |
| Bac, P; Delcourt, P; Herrenknecht, C; Maurois, P; Stables, JP; Vamecq, J | 1 |
2 other study(ies) available for 2,6-dimethylphenylphthalimide and Seizures
| Article | Year |
|---|---|
Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide.
Topics: Administration, Oral; Animals; Anticonvulsants; Batrachotoxins; Benzamides; Binding, Competitive; Brain; Electroshock; Injections, Intraperitoneal; Ion Channel Gating; Mice; Rats; Seizures; Sodium Channels; Structure-Activity Relationship; Synaptosomes | 1998 |
Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore.
Topics: Administration, Oral; Animals; Anticonvulsants; Batrachotoxins; Cerebral Cortex; Convulsants; Electroshock; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; In Vitro Techniques; Ion Channel Gating; Kainic Acid; Magnesium Deficiency; Mice; N-Methylaspartate; Patch-Clamp Techniques; Pentylenetetrazole; Phenytoin; Phthalimides; Rats; Seizures; Sodium Channel Blockers; Structure-Activity Relationship; Synaptosomes; Tumor Cells, Cultured | 2000 |